$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000155837022002452 Filed on March 01, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$30.95M	$7.308M	$28.11M
YoY Change	10.09%	0.63%	8.82%
Cost Of Revenue	$28.88M	$6.720M	$26.67M
YoY Change	8.27%	-4.51%	3.31%
Gross Profit	$2.069M	$588.0K	$1.438M
YoY Change	43.88%	161.65%	9851.56%
Gross Profit Margin	6.69%	8.05%	5.12%
Selling, General & Admin	$25.88M	$5.162M	$14.97M
YoY Change	72.87%	34.52%	15.57%
% of Gross Profit	1250.89%	877.89%	1041.1%
Research & Development	$3.274M	$1.410M	$4.128M
YoY Change	-20.69%	-13.31%	-48.77%
% of Gross Profit	158.24%	239.8%	287.07%
Depreciation & Amortization	$633.0K	$348.0K	$688.0K
YoY Change	-7.99%	10.85%	16.81%
% of Gross Profit	30.59%	59.18%	47.84%
Operating Expenses	$30.48M	$6.805M	$20.62M
YoY Change	47.82%	17.78%	-12.55%
Operating Profit	-$28.41M	-$6.248M	-$19.18M
YoY Change	48.11%	12.54%	-18.6%
Interest Expense	$58.00K	$394.0K	$72.00K
YoY Change	-19.44%	-161.04%	28.57%
% of Operating Profit
Other Income/Expense, Net	-$4.183M	$128.0K	-$490.0K
YoY Change	753.67%	-112.67%	-83.62%
Pretax Income	-$32.60M	-$6.404M	-$19.67M
YoY Change	65.68%	3.32%	-25.92%
Income Tax	$14.00K	$0.00	$38.00K
% Of Pretax Income
Net Earnings	-$32.61M	-$6.405M	-$19.71M
YoY Change	65.44%	3.34%	-25.78%
Net Earnings / Revenue	-105.37%	-87.64%	-70.12%
Basic Earnings Per Share	-$0.21		-$0.14
Diluted Earnings Per Share	-$0.21	-$46.10K	-$0.14
COMMON SHARES
Basic Shares Outstanding	156.2M	138.9M	138.8M
Diluted Shares Outstanding	156.2M		138.8M

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.74M	$22.34M	$22.34M
YoY Change	118.14%	-42.66%	-42.66%
Cash & Equivalents	$1.336M	$1.029M
Short-Term Investments	$47.40M	$21.31M	$21.31M
Other Short-Term Assets	$2.183M	$1.806M	$1.806M
YoY Change	20.87%	178.64%	178.64%
Inventory	$2.881M	$2.034M	$2.034M
Prepaid Expenses
Receivables	$585.0K	$2.159M	$2.159M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$54.39M	$28.34M	$28.34M
YoY Change	91.9%	-33.69%	-33.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.564M	$2.483M	$2.730M
YoY Change	177.07%	-33.29%	-26.65%
Goodwill
YoY Change
Intangibles		$8.211M
YoY Change		-3.33%
Long-Term Investments	$2.345M	$6.536M	$6.536M
YoY Change	-64.12%	-22.21%	-22.21%
Other Assets		$5.876M
YoY Change
Total Long-Term Assets	$21.57M	$23.35M	$23.35M
YoY Change	-7.64%	-10.89%	-10.89%
TOTAL ASSETS
Total Short-Term Assets	$54.39M	$28.34M	$28.34M
Total Long-Term Assets	$21.57M	$23.35M	$23.35M
Total Assets	$75.95M	$51.69M	$51.69M
YoY Change	46.93%	-25.03%	-25.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.173M	$1.116M	$1.116M
YoY Change	94.71%	-44.12%	-44.14%
Accrued Expenses	$5.539M	$931.0K	$5.416M
YoY Change	2.27%	-64.45%	69.41%
Deferred Revenue		$272.0K
YoY Change		5340.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$596.0K	$539.0K	$539.0K
YoY Change	10.58%	-7.18%	-7.18%
Total Short-Term Liabilities	$8.427M	$7.343M	$7.343M
YoY Change	14.76%	27.02%	27.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$1.453M	$241.0K	$241.0K
YoY Change	502.9%	-70.89%	-70.89%
Total Long-Term Liabilities	$1.453M	$241.0K	$241.0K
YoY Change	502.9%	-78.48%	-78.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.427M	$7.343M	$7.343M
Total Long-Term Liabilities	$1.453M	$241.0K	$241.0K
Total Liabilities	$9.880M	$7.584M	$7.584M
YoY Change	30.27%	9.9%	9.9%
SHAREHOLDERS EQUITY
Retained Earnings		-$145.4M
YoY Change		15.68%
Common Stock		$1.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$66.07M	$44.11M	$44.11M
YoY Change
Total Liabilities & Shareholders Equity	$75.95M	$51.69M	$51.69M
YoY Change	46.93%	-25.03%	-25.03%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	-$32.61M	-$6.405M	-$19.71M
YoY Change	65.44%	3.34%	-25.78%
Depreciation, Depletion And Amortization	$633.0K	$348.0K	$688.0K
YoY Change	-7.99%	10.85%	16.81%
Cash From Operating Activities	-$22.84M	-$2.997M	-$15.62M
YoY Change	46.21%	3.71%	7.08%
INVESTING ACTIVITIES
Capital Expenditures	$745.0K	-$147.0K	$54.00K
YoY Change	1279.63%	20.65%	-89.75%
Acquisitions
YoY Change
Other Investing Activities	-$26.66M	$3.861M	$16.99M
YoY Change	-256.89%	-151.92%	232.03%
Cash From Investing Activities	-$27.73M	$3.714M	$16.47M
YoY Change	-268.37%	-149.14%	261.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$38.21M
YoY Change
Debt Paid & Issued, Net			$1.183M
YoY Change
Cash From Financing Activities	50.88M	-1.230M	-304.0K
YoY Change	-16835.2%	-111.92%	-103.07%
NET CHANGE
Cash From Operating Activities	-22.84M	-2.997M	-15.62M
Cash From Investing Activities	-27.73M	3.714M	16.47M
Cash From Financing Activities	50.88M	-1.230M	-304.0K
Net Change In Cash	307.0K	-513.0K	544.0K
YoY Change	-43.57%	286.67%	-553.33%
FREE CASH FLOW
Cash From Operating Activities	-$22.84M	-$2.997M	-$15.62M
Capital Expenditures	$745.0K	-$147.0K	$54.00K
Free Cash Flow	-$23.58M	-$2.850M	-$15.68M
YoY Change	50.46%	2.96%	3.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156208000
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1336000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1029000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156208000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138813000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138813000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125883000
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125883000
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021	xxii	Maximum Maturity Date Of Securities MaximumMaturityDateOfSecurities	P24M
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162872875
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139061690
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P9M
CY2020Q2	xxii	Directors And Officers Insurance Policy Term DirectorsAndOfficersInsurancePolicyTerm	P1Y
CY2020Q2	xxii	Postemployment Benefit Period PostemploymentBenefitPeriod	P12M
CY2019	xxii	Postemployment Benefit Period PostemploymentBenefitPeriod	P42M
CY2019Q4	xxii	Warrants Consecutive Trading Days WarrantsConsecutiveTradingDays	P10D
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-36338
CY2021	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0468420
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Seneca Street, Suite 507
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Buffalo
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14204
CY2021	dei	City Area Code CityAreaCode	716
CY2021	dei	Local Phone Number LocalPhoneNumber	270-1523
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
CY2021	dei	Trading Symbol TradingSymbol	XXII
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	740000000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	162938375
CY2021	dei	Auditor Firm AuditorFirmId	317
CY2021	dei	Auditor Name AuditorName	Freed Maxick, CPAs, P.C.
CY2021	dei	Auditor Location AuditorLocation	Buffalo, New York
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	47400000
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	21313000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	585000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2159000
CY2021Q4	us-gaap	Inventory Net InventoryNet	2881000
CY2020Q4	us-gaap	Inventory Net InventoryNet	2034000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2183000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1806000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	54385000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	28341000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5841000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2483000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1723000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	247000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7919000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8211000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	2345000
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	6536000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3741000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5876000
CY2021Q4	us-gaap	Assets Assets	75954000
CY2020Q4	us-gaap	Assets Assets	51694000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	596000
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	539000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	308000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	247000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2173000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1116000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1489000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	931000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2255000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2208000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1270000
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1691000
CY2021Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	217000
CY2020Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	339000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	119000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	272000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8427000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7343000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1432000
CY2021Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	21000
CY2020Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	241000
CY2021Q4	us-gaap	Liabilities Liabilities	9880000
CY2020Q4	us-gaap	Liabilities Liabilities	7584000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162872875
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139061690
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	244247000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	189439000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-162000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	74000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178013000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-145404000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	66074000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44110000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75954000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51694000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30948000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28111000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25833000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	28879000
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	26673000
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	25818000
CY2021	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	2069000
CY2020	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	1438000
CY2019	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	15000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25881000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14971000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12954000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	78000
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	176000
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1142000
CY2021	us-gaap	Depreciation Depreciation	633000
CY2020	us-gaap	Depreciation Depreciation	688000
CY2019	us-gaap	Depreciation Depreciation	589000
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	615000
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	658000
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	836000
CY2021	us-gaap	Operating Expenses OperatingExpenses	30481000
CY2020	us-gaap	Operating Expenses OperatingExpenses	20621000
CY2019	us-gaap	Operating Expenses OperatingExpenses	23581000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-28412000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-19183000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-23566000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6994000
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-434000
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2419000
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	1741000
CY2021	xxii	Debt Securities Realized Gain Loss On Conversion DebtSecuritiesRealizedGainLossOnConversion	2548000
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	5000
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	221000
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1891000
CY2020	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	1000
CY2019	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	87000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	321000
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	1751000
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	1066000
CY2021	us-gaap	Interest Expense InterestExpense	58000
CY2020	us-gaap	Interest Expense InterestExpense	72000
CY2019	us-gaap	Interest Expense InterestExpense	56000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4183000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-490000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2992000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32595000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19673000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26558000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32609000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19711000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26558000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-236000
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	72000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	207000
CY2020	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	5000
CY2019	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	221000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-236000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	67000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32845000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19644000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26572000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156208000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138813000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125883000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	71278000
CY2019	xxii	Stock Issued During Period Value Warrants Exercise StockIssuedDuringPeriodValueWarrantsExercise	10616000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3540000
CY2019	xxii	Stock Issued During Period Value Litigation Expense StockIssuedDuringPeriodValueLitigationExpense	1891000
CY2019	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1297000
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	207000
CY2019	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-221000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26558000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	50000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	62050000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1654000
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	72000
CY2020	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19711000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	44110000
CY2021	xxii	Stock Issued During Period Value Warrants Exercise StockIssuedDuringPeriodValueWarrantsExercise	11782000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1307000
CY2021	xxii	Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes	-469000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38206000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3983000
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-236000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32609000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	66074000
CY2021	us-gaap	Profit Loss ProfitLoss	-32609000
CY2020	us-gaap	Profit Loss ProfitLoss	-19711000
CY2019	us-gaap	Profit Loss ProfitLoss	-26558000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	78000
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	176000
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1142000
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	1741000
CY2021	xxii	Amortization And Depreciation Excluding Amortization Of Intangibles AmortizationAndDepreciationExcludingAmortizationOfIntangibles	999000
CY2020	xxii	Amortization And Depreciation Excluding Amortization Of Intangibles AmortizationAndDepreciationExcludingAmortizationOfIntangibles	1094000
CY2019	xxii	Amortization And Depreciation Excluding Amortization Of Intangibles AmortizationAndDepreciationExcludingAmortizationOfIntangibles	1186000
CY2021	xxii	Amortization Of License Fees AmortizationOfLicenseFees	249000
CY2020	xxii	Amortization Of License Fees AmortizationOfLicenseFees	251000
CY2019	xxii	Amortization Of License Fees AmortizationOfLicenseFees	239000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	288000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	182000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	212000
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6994000
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-434000
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2419000
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	5000
CY2019	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	221000
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1891000
CY2020	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	1000
CY2019	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	87000
CY2021	xxii	Debt Securities Realized Gain Loss On Conversion DebtSecuritiesRealizedGainLossOnConversion	2548000
CY2021	xxii	Accretion Income AccretionIncome	-143000
CY2020	xxii	Accretion Income AccretionIncome	326000
CY2019	xxii	Accretion Income AccretionIncome	-26000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3983000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1654000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3540000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	317000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	521000
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	985000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1574000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1292000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1164000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	289000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	207000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	547000
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	787000
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-280000
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-272000
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-552000
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-212000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-936000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-732000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	533000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	499000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	243000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	47000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1121000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	498000
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-421000
CY2020	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	563000
CY2019	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	51000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-341000
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-225000
CY2019	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	792000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-153000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	267000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-78000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22839000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15621000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14588000
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	326000
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	468000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	565000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	745000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	527000
CY2020	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	6000
CY2019	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	166000
CY2019	xxii	Payments To Acquire Investment Including Receivable And Equity Securities PaymentsToAcquireInvestmentIncludingReceivableAndEquitySecurities	12000000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	63749000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	39728000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	19320000
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	90407000
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	22743000
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1842000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27729000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16469000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4552000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2604000
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2549000
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	700000
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2653000
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2195000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1307000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	50000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11782000
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	10616000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	38206000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	469000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1183000
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1183000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50875000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-304000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9916000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	307000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	544000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-120000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1029000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	485000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	605000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1336000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1029000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	485000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	37000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	29000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3000
CY2021	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	51000
CY2020	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	55000
CY2019	xxii	Patent And Trademark Additions Included In Accounts Payable PatentAndTrademarkAdditionsIncludedInAccountsPayable	155000
CY2021	xxii	Property Plant And Equipment Additions Included In Accounts Payable PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable	998000
CY2020	xxii	Property Plant And Equipment Additions Included In Accounts Payable PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable	2000
CY2021	xxii	Right Of Use Assets And Corresponding Operating Lease Obligations RightOfUseAssetsAndCorrespondingOperatingLeaseObligations	1816000
CY2020	xxii	Right Of Use Assets And Corresponding Operating Lease Obligations RightOfUseAssetsAndCorrespondingOperatingLeaseObligations	198000
CY2019	xxii	Right Of Use Assets And Corresponding Operating Lease Obligations RightOfUseAssetsAndCorrespondingOperatingLeaseObligations	814000
CY2021	xxii	Patent And Trademark Additions Included In Accrued Liabilities Current PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent	25000
CY2020	xxii	Patent And Trademark Additions Included In Accrued Liabilities Current PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent	28000
CY2019	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1297000
CY2021	xxii	Noncash Investment Conversion NoncashInvestmentConversion	12485000
CY2021	xxii	Number Of Subsidiaries NumberOfSubsidiaries	4
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risk </span>– Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institutions. Although the cash accounts exceed the federally insured deposit amount, management does not anticipate nonperformance by the financial institutions. Management reviews the financial viability of these institutions on a periodic basis.</p>
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span>–<b style="font-weight:bold;"> </b>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q4	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	1352000
CY2020Q4	xxii	Inventory Tobacco Leaf Gross InventoryTobaccoLeafGross	821000
CY2021Q4	xxii	Inventory Hemp Cannabis Gross InventoryHempCannabisGross	10000
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	256000
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	171000
CY2021Q4	xxii	Inventory Raw Materials Excluding Tobacco Leaf InventoryRawMaterialsExcludingTobaccoLeaf	1363000
CY2020Q4	xxii	Inventory Raw Materials Excluding Tobacco Leaf InventoryRawMaterialsExcludingTobaccoLeaf	1142000
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2021Q4	us-gaap	Inventory Net InventoryNet	2881000
CY2020Q4	us-gaap	Inventory Net InventoryNet	2034000
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	521000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3300000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2670000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5841000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2483000
CY2021	us-gaap	Depreciation Depreciation	633000
CY2020	us-gaap	Depreciation Depreciation	688000
CY2019	us-gaap	Depreciation Depreciation	589000
CY2021	xxii	Lessee Operating Lease Number Of One Year Renewal Options LesseeOperatingLeaseNumberOfOneYearRenewalOptions	3
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	373000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	429000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	448000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	418000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	111000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	108000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1887000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	147000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1740000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	301000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	335000
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	250000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7919000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8211000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	615000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	658000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	836000
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	176000
CY2020	xxii	Finite Lived Intangible Assets Written Off Due To Impairment Cost FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost	448000
CY2020	xxii	Finite Lived Intangible Assets Written Off Due To Impairment Accumulated Amortization FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization	302000
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1142000
CY2019	xxii	Finite Lived Intangible Assets Written Off Due To Impairment Cost FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost	2092000
CY2019	xxii	Finite Lived Intangible Assets Written Off Due To Impairment Accumulated Amortization FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization	950000
CY2019Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	1297000
CY2019Q4	us-gaap	Share Price SharePrice	1
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	2345000
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	6536000
CY2020Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	5876000
CY2021Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	3741000
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	11127000
CY2020	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	434000
CY2020	xxii	Accreted Interest Income On Convertible Note Receivable AccretedInterestIncomeOnConvertibleNoteReceivable	595000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	11288000
CY2021	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	233000
CY2021	xxii	Accreted Interest Income On Convertible Note Receivable AccretedInterestIncomeOnConvertibleNoteReceivable	142000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	11192000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	5000
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	23652000
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	74000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	23726000
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	8286000
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	8280000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	11692000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	11753000
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	30357000
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	30201000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	11960000
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	11973000
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	38643000
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	38481000
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	23652000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	23726000
CY2020Q2	xxii	Borrowings Under Paycheck Protection Program BorrowingsUnderPaycheckProtectionProgram	1200000
CY2021Q2	xxii	Directors And Officers Insurance Policy Term DirectorsAndOfficersInsurancePolicyTerm	P1Y
CY2021Q2	xxii	Directors And Officers Insurance Premium DirectorsAndOfficersInsurancePremium	3315000
CY2021Q2	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	662000
CY2021Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2653000
CY2021Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P9M
CY2021Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0349
CY2020Q2	xxii	Directors And Officers Insurance Premium DirectorsAndOfficersInsurancePremium	2744000
CY2020Q2	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	549000
CY2020Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2195000
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0319
CY2020Q4	xxii	License Fees Payable Current LicenseFeesPayableCurrent	293000
CY2021Q4	xxii	Directors And Officers Insurance Payable Current DirectorsAndOfficersInsurancePayableCurrent	596000
CY2020Q4	xxii	Directors And Officers Insurance Payable Current DirectorsAndOfficersInsurancePayableCurrent	246000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	596000
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	539000
CY2020Q2	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	306000
CY2019	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	881000
CY2019Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	771000
CY2021Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	217000
CY2021Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	21000
CY2020Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	339000
CY2020Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	241000
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10000000
CY2021Q2	us-gaap	Share Price SharePrice	4.00
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38206000
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.11
CY2019Q4	xxii	Warrant Notice Price Per Share WarrantNoticePricePerShare	0.001
CY2019Q4	xxii	Warrants Weighted Average Price WarrantsWeightedAveragePrice	3.00
CY2021Q1	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	-11293211
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11782000
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11293211
CY2019	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	11293211
CY2019	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11293211
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11293211
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11293211
CY2021	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	11293211
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.03
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	171000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	150000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	157000
CY2021Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	2893000
CY2021Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	2118000
CY2021Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1337000
CY2021Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	1374000
CY2021Q4	xxii	Contractual Obligation Due After Fourth Year ContractualObligationDueAfterFourthYear	2730000
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	10452000
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	990000
CY2019Q3	xxii	Litigation Settlement Period Of Voting Priviledge LitigationSettlementPeriodOfVotingPriviledge	P5Y
CY2019Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	1891000
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	990000
CY2019Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	3
CY2020Q1	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	3
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32609000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-19711000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26558000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156208000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138813000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125883000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8336000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20812000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20081000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	5000000
CY2021	xxii	Share Based Compensation Arrangement Plan Term ShareBasedCompensationArrangementPlanTerm	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7526630
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1301000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.21
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	100000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.02
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	250000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.02
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	951000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.15
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2885000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.71
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	325000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.07
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	573000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.90
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2938000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.85
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2200000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.25
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1660000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.85
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	313000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.04
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3165000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	5262000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	601000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8672000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.54
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	600000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.07
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	75000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.93
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1360000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.09
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7837000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.49
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	399000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.04
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	169000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.83
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	688000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.51
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6581000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.50
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	235000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.10
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	984000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.37
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	600000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	61000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.64
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5171000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.65
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M6D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7431000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4836000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.56
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	7375000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0054
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0154
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8792
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M2D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y1M24D
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3983000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1654000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	3540000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4685000
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y9M18D
CY2021Q4	xxii	Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting	517000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7566000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3932000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5607000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-200000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	55000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7567000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4132000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5552000
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	7581000
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	4170000
CY2019	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	5552000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	-0.005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.015
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.027
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.007
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.018
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.002
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.233
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.214
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.209
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24859000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18498000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14996000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	104000
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	115000
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	52000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1326000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1099000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1049000
CY2021Q4	xxii	Deferred Tax Liabilities Start Up Expenditures DeferredTaxLiabilitiesStartUpExpenditures	177000
CY2020Q4	xxii	Deferred Tax Liabilities Start Up Expenditures DeferredTaxLiabilitiesStartUpExpenditures	199000
CY2019Q4	xxii	Deferred Tax Liabilities Start Up Expenditures DeferredTaxLiabilitiesStartUpExpenditures	221000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1192000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1171000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1209000
CY2021Q4	xxii	Deferred Tax Assets Accrued Bonus DeferredTaxAssetsAccruedBonus	411000
CY2020Q4	xxii	Deferred Tax Assets Accrued Bonus DeferredTaxAssetsAccruedBonus	423000
CY2019Q4	xxii	Deferred Tax Assets Accrued Bonus DeferredTaxAssetsAccruedBonus	200000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	50000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	122000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	134000
CY2021Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	1366000
CY2020Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	371000
CY2019Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	40000
CY2021Q4	xxii	Deferred Tax Assets Operating Lease Obligations DeferredTaxAssetsOperatingLeaseObligations	365000
CY2020Q4	xxii	Deferred Tax Assets Operating Lease Obligations DeferredTaxAssetsOperatingLeaseObligations	52000
CY2019Q4	xxii	Deferred Tax Assets Operating Lease Obligations DeferredTaxAssetsOperatingLeaseObligations	127000
CY2021Q4	xxii	Deferred Tax Assets Capital Loss On Investment DeferredTaxAssetsCapitalLossOnInvestment	107000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	18000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	18000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29975000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22068000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18050000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	254000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	237000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	239000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	373000
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	358000
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	351000
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	13000
CY2019Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	104000
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	24000
CY2019Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	51000
CY2021Q4	xxii	Deferred Tax Liabilities Operating Lease Righ Tof Use Asset DeferredTaxLiabilitiesOperatingLeaseRighTofUseAsset	362000
CY2020Q4	xxii	Deferred Tax Liabilities Operating Lease Righ Tof Use Asset DeferredTaxLiabilitiesOperatingLeaseRighTofUseAsset	52000
CY2019Q4	xxii	Deferred Tax Liabilities Operating Lease Righ Tof Use Asset DeferredTaxLiabilitiesOperatingLeaseRighTofUseAsset	126000
CY2021Q4	xxii	Deferred Tax Liabilities Other Intangible Assets DeferredTaxLiabilitiesOtherIntangibleAssets	259000
CY2020Q4	xxii	Deferred Tax Liabilities Other Intangible Assets DeferredTaxLiabilitiesOtherIntangibleAssets	224000
CY2019Q4	xxii	Deferred Tax Liabilities Other Intangible Assets DeferredTaxLiabilitiesOtherIntangibleAssets	189000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1248000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	908000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1060000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28779000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21198000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16990000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	52000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	38000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	70658000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	46920000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1192000
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	510000
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2021	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	10135000
CY2020	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	9859000
CY2019	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	9187000
CY2021	xxii	Contract Asset Payment Period After Shipment ContractAssetPaymentPeriodAfterShipment	P21D
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	178000
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	349000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	119000
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	272000
CY2021Q4	xxii	Contract Asset Liability Net ContractAssetLiabilityNet	59000
CY2020Q4	xxii	Contract Asset Liability Net ContractAssetLiabilityNet	77000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30948000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28111000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25833000
CY2021	xxii	Risk Concentration Number Of Customers Comprising Specified Concentration RiskConcentrationNumberOfCustomersComprisingSpecifiedConcentration	3
CY2020	xxii	Risk Concentration Number Of Customers Comprising Specified Concentration RiskConcentrationNumberOfCustomersComprisingSpecifiedConcentration	2
CY2019	xxii	Risk Concentration Number Of Customers Comprising Specified Concentration RiskConcentrationNumberOfCustomersComprisingSpecifiedConcentration	3

Files In Submission

Name	View Source	Status
0001558370-22-002452-index-headers.html	Edgar Link	pending
0001558370-22-002452-index.html	Edgar Link	pending
0001558370-22-002452.txt	Edgar Link	pending
0001558370-22-002452-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xxii-20211231.xsd	Edgar Link	pending
xxii-20211231x10k.htm	Edgar Link	pending
xxii-20211231x10k002.jpg	Edgar Link	pending
xxii-20211231x10k_htm.xml	Edgar Link	completed
xxii-20211231xex23d1.htm	Edgar Link	pending
xxii-20211231xex31d1.htm	Edgar Link	pending
xxii-20211231xex31d2.htm	Edgar Link	pending
xxii-20211231xex32d1.htm	Edgar Link	pending
xxii-20211231xex4d1.htm	Edgar Link	pending
xxii-20211231_cal.xml	Edgar Link	unprocessable
xxii-20211231_def.xml	Edgar Link	unprocessable
xxii-20211231_lab.xml	Edgar Link	unprocessable
xxii-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2021 Form 10-K Financial Statement

#000155837022002452 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2021 Form 10-K Financial Statement

#000155837022002452 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii